Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and tolerability of MS-R001 at
escalating doses in patients with diabetic macular edema secondary to diabetic retinopathy